Lv0
0 积分 2026-02-09 加入
Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
1个月前
已完结
First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa
1个月前
已完结
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders
1个月前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
1个月前
已完结
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy
1个月前
已完结
皖公网安备34019202002308
